[{"NetIncomeLoss_2_Q1_USD":1915204.0,"RepaymentsOfRelatedPartyDebt_2_Q1_USD":136833.0,"AssetsCurrent_0_Q1_USD":1345929.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":396983.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":250204170.0,"NetCashProvidedByUsedInInvestingActivities_2_Q1_USD":-276000000.0,"OperatingCostsAndExpenses_1_Q1_USD":1222047.0,"CommitmentsAndContingencies_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_1_Q1_USD":0.0,"ProceedsFromRelatedPartyDebt_2_Q1_USD":91306.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q1_USD":1654400.0,"Liabilities_0_Q1_USD":23559649.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":749099.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":-3126934.0,"FairValueAdjustmentOfWarrants_2_Q1_USD":-3126934.0,"PaymentsOfStockIssuanceCosts_2_Q1_USD":401506.0,"NetCashProvidedByUsedInFinancingActivities_2_Q1_USD":277552967.0,"AssetsHeldInTrustNoncurrent_0_Q1_USD":276010317.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q1_USD":749099.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q1_USD":395333.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":3137251.0,"Cash_0_Q1_USD":749099.0,"ProceedsFromInterestReceived_1_Q1_USD":0.0,"Assets_0_Q1_USD":277356246.0,"UnrealizedGainLossOnInvestments_2_Q1_USD":4595.0,"NetIncomeLoss_1_Q1_USD":1915204.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"AdditionalPaidInCapital_0_Q1_USD":0.0,"LiabilitiesCurrent_0_Q1_USD":396983.0,"NetCashProvidedByUsedInOperatingActivities_2_Q1_USD":-803868.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":4595.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":1915204.0,"PaymentsToAcquireRestrictedInvestments_2_Q1_USD":276000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-22204093.0,"StockholdersEquity_0_Q1_USD":-22203403.0,"ProfitLoss_1_Q1_USD":1915204.0,"CashFDICInsuredAmount_0_Q1_USD":250000.0,"SharePrice_0_Q1_USD":10.0,"ProceedsFromIssuanceOfWarrants_2_Q1_USD":7520000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":227356246.0,"PreferredStockValue_0_Q1_USD":null,"InvestmentIncomeInterest_1_Q1_USD":5722.0,"OperatingIncomeLoss_1_Q1_USD":-1222047.0,"RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0_Q1_USD":276000000.0,"ProceedsFromIssuanceOfCommonStock_2_Q1_USD":270480000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"StockholdersEquityOther_1_Q1_USD":-276000000.0,"PrepaidExpenseCurrent_0_Q1_USD":596830.0,"IncreaseDecreaseInPrepaidExpense_2_Q1_USD":596830.0,"Ticker":"PEAR","CIK":"1835567","name":"THIMBLE POINT ACQUISITION CORP.","OfficialName":"Pear Therapeutics Inc. Class A Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"621640486.0","Country":"United States","Sector":"Technology","Industry":"Computer Software: Prepackaged Software","Market":"NASDAQ","SP500":"nan","filed":"20210524"}]